Docket Number:13A-1060427
Inventor:Hanna Shiao-Han Yuan, Jason Liang-ju Lin
IP Status:PCT pending
Abstract:
The subject provided herein related to a pharmaceutical composition containing modulators of EndoG, and their use in the treatment and prevention of diseases or disorders that would benefit from increased mitochondrial activity, such as cardiovascular diseases, anxiety disorders, diabetes, neurodegenerative diseases, inflammation, and/or cancers. The EndoG-modulating compounds stabilize EndoG and increase EndoG’s activity and promote mitochondrial functions.
Fields of Application:
The present invention relates to chemical compounds of the EndoG modulators that may be used for treating and/or preventing a wide variety of diseases and disorders including but not limited to the diseases or disorders related to aging or stress, diabetes, neurodegenerative diseases, cardiovascular disease, anxiety disorders, inflammation, and/or cancer as well as diseases or disorders that would benefit from increased mitochondrial activity.
Advantages when compared to the existing technologies:
The SIRT1-modulating compounds have been developed for increasing lifespan, and prevention and treatment of various diseases, including cancer, diabetes, cardiovascular and neurodegenerative diseases. However, these modulators bind to SIRT1 with a low milli-molor to micro-molar affinity.
In contrast, the EndoG-modulating compounds identified in this invention bind to EndoG with a high nano-molar affinity and they significantly increase EndoG’s nuclease activity at low concentrations, suggesting that they may be used as therapeutic agents for prevention and treatment of a wide variety of diseases and disorders that are associated with decreased mitochondrial function.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
